ライフサイエンスコーパス: arterial graft

1 or foreign-body reaction, such as synthetic arterial graft.

2 er than 10% of cases receiving more than one arterial graft.

3 w be treated by endovascular placement of an arterial graft.

4 ement, and particularly when using composite arterial grafts.

5 Only 14 patients (21%) had received previous arterial grafts.

6 /-0.9 vs 3.3+/-0.9; P<0.001), but more total arterial grafting (45.9% vs 8.4%; P<0.001).

7 matched patients (2-arterial graft: 5346; 3-arterial graft: 4941) were selected for final comparison

8 dies reporting on 10 287 matched patients (2-arterial graft: 5346; 3-arterial graft: 4941) were selec

9 atient was 3.27 +/- 0.93, with 2.76 +/- 0.97 arterial grafts; a mean of 1.53 +/- 0.68 grafts were per

10 terogeneity and worse clinical outcomes than arterial grafts (AGs), we examined oxidative stress and

11 Five year arterial graft and patient survival for patients who hav

12 nt died of an infected pseudoaneurysm of the arterial graft, and the pediatric patient required repea

13 consider lowering their threshold for using arterial grafts, and the radial artery may be the prefer

14 (n=3), ACR with severe infection (n=1), and arterial graft aneurysm (n=1).

15 In contrast, arterial grafts are relatively resistant to these proces

16 Arterial grafts are thought to be better conduits than s

17 ost-CABG risk factor reduction and extensive arterial grafting at primary operation should decrease c

18 ow a survival benefit from a third or fourth arterial graft, but we believe that complete arterial re

19 Multiple arterial grafting confers superior long-term outcomes in

20 on at the time of LTx, and use of infrarenal arterial graft contribute to development of PTAP in chil

21 he thrombus, first to the venous then to the arterial graft end.

22 he radial artery is often used as the second arterial graft for coronary artery bypass grafting.

23 Arterial grafts for CABG have been used increasingly, an

24 All patients required interposition arterial grafts from the aorta and hepatojejunostomy for

25 data for the long-term outcomes of multiple arterial grafting in terms of patient selection, conduit

26 superior outcomes compared with the use of 2 arterial grafts in patients undergoing coronary artery b

27 Patients were stratified by number of arterial grafts into the LIMA plus saphenous veins (LIMA

28 the long-term survival advantage of multiple arterial grafting (MAG) vs the standard use of left inte

29 benefit of long-term patency associated with arterial grafts, minimal morbidity and mortality associa

30 re detected and included complete or partial arterial graft occlusion, stenosis of the arterial Y-gra

31 ith LIMA to left anterior descending artery, arterial grafting of the non-left anterior descending ve

32 f CABG with particular reference to multiple arterial grafts, off-pump and less invasive CABG, graft

33 Multiple arterial grafting or LITA+SVG.

34 Left and right internal thoracic artery (arterial) graft patency has been shown to be superior to

35 verage grafts per patient were 3.8, with 2.4 arterial grafts per patient.

36 Increasing extent of arterial grafting performed at primary operation decreas

37 The use of composite arterial grafts performed on the beating heart may be th

38 vascularization (UR), using an interposition arterial graft procured from the cadaveric liver donor,

39 Little evidence shows whether a third arterial graft provides superior outcomes compared with

40 ntation survived, including 14 controls with arterial grafts receiving no PBMC.

41 Multiple arterial grafting remains poorly utilized, with fewer th

42 ater propensity for intimal hyperplasia than arterial grafts; the human radial artery behaves similar

43 bypass because of the relative resistance of arterial grafts to atherosclerosis compared with autogen

44 of transplant arteriosclerosis (TA) in human arterial grafts transplanted into immunodeficient BALB/c

45 ly, however, the positive effect of a second arterial graft was confirmed.

46 Multiple arterial grafting was not associated with increased morb

47 The use of 3 arterial grafts was associated with statistically signif

48 The use of 3 arterial grafts was not statistically associated with ea

49 grafting with the use of 2-arterial versus 3-arterial grafts was performed.

50 e the feasibility of transgene expression in arterial grafts, we performed such permeabilization-assi

51 use in California is low and declining, but arterial grafts were associated with significantly lower

52 In 7 patients, pulmonary arterial grafts were used; in 3 patients, monocusp pulmo

53 s in a patient who demonstrated infra-aortic arterial graft, which clotted by the gravid uterus durin